nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadoteridol—Neck stiffness—Methotrexate—ankylosing spondylitis	0.0163	0.0163	CcSEcCtD
Gadoteridol—Nuchal rigidity—Methotrexate—ankylosing spondylitis	0.015	0.015	CcSEcCtD
Gadoteridol—Tingling sensation—Methylprednisolone—ankylosing spondylitis	0.0146	0.0146	CcSEcCtD
Gadoteridol—Tingling sensation—Dexamethasone—ankylosing spondylitis	0.0133	0.0133	CcSEcCtD
Gadoteridol—Tingling sensation—Betamethasone—ankylosing spondylitis	0.0133	0.0133	CcSEcCtD
Gadoteridol—Fluid retention—Prednisolone—ankylosing spondylitis	0.0121	0.0121	CcSEcCtD
Gadoteridol—Wheezing—Triamcinolone—ankylosing spondylitis	0.0114	0.0114	CcSEcCtD
Gadoteridol—Fluid retention—Triamcinolone—ankylosing spondylitis	0.0112	0.0112	CcSEcCtD
Gadoteridol—Fluid retention—Methylprednisolone—ankylosing spondylitis	0.0111	0.0111	CcSEcCtD
Gadoteridol—Cyanosis—Methotrexate—ankylosing spondylitis	0.011	0.011	CcSEcCtD
Gadoteridol—Stupor—Methotrexate—ankylosing spondylitis	0.0104	0.0104	CcSEcCtD
Gadoteridol—Fluid retention—Betamethasone—ankylosing spondylitis	0.0101	0.0101	CcSEcCtD
Gadoteridol—Fluid retention—Dexamethasone—ankylosing spondylitis	0.0101	0.0101	CcSEcCtD
Gadoteridol—Gingivitis—Methotrexate—ankylosing spondylitis	0.00989	0.00989	CcSEcCtD
Gadoteridol—Anaphylactoid reaction—Prednisolone—ankylosing spondylitis	0.00958	0.00958	CcSEcCtD
Gadoteridol—Apnoea—Methotrexate—ankylosing spondylitis	0.00915	0.00915	CcSEcCtD
Gadoteridol—Cardiac arrest—Prednisolone—ankylosing spondylitis	0.00882	0.00882	CcSEcCtD
Gadoteridol—Fluid retention—Prednisone—ankylosing spondylitis	0.00881	0.00881	CcSEcCtD
Gadoteridol—Anaphylactoid reaction—Triamcinolone—ankylosing spondylitis	0.00881	0.00881	CcSEcCtD
Gadoteridol—Anaphylactoid reaction—Methylprednisolone—ankylosing spondylitis	0.00879	0.00879	CcSEcCtD
Gadoteridol—Musculoskeletal stiffness—Methotrexate—ankylosing spondylitis	0.00865	0.00865	CcSEcCtD
Gadoteridol—Cardiac arrest—Triamcinolone—ankylosing spondylitis	0.00811	0.00811	CcSEcCtD
Gadoteridol—Cardiac arrest—Methylprednisolone—ankylosing spondylitis	0.00809	0.00809	CcSEcCtD
Gadoteridol—Anaphylactoid reaction—Betamethasone—ankylosing spondylitis	0.008	0.008	CcSEcCtD
Gadoteridol—Anaphylactoid reaction—Dexamethasone—ankylosing spondylitis	0.008	0.008	CcSEcCtD
Gadoteridol—Depressed level of consciousness—Methotrexate—ankylosing spondylitis	0.00749	0.00749	CcSEcCtD
Gadoteridol—Cardiac arrest—Dexamethasone—ankylosing spondylitis	0.00736	0.00736	CcSEcCtD
Gadoteridol—Cardiac arrest—Betamethasone—ankylosing spondylitis	0.00736	0.00736	CcSEcCtD
Gadoteridol—Bradycardia—Prednisolone—ankylosing spondylitis	0.00653	0.00653	CcSEcCtD
Gadoteridol—Face oedema—Prednisone—ankylosing spondylitis	0.00651	0.00651	CcSEcCtD
Gadoteridol—Cardiac arrest—Prednisone—ankylosing spondylitis	0.00641	0.00641	CcSEcCtD
Gadoteridol—Sweating—Methylprednisolone—ankylosing spondylitis	0.00629	0.00629	CcSEcCtD
Gadoteridol—Bradycardia—Triamcinolone—ankylosing spondylitis	0.00601	0.00601	CcSEcCtD
Gadoteridol—Bradycardia—Methylprednisolone—ankylosing spondylitis	0.00599	0.00599	CcSEcCtD
Gadoteridol—Rhinitis—Triamcinolone—ankylosing spondylitis	0.00592	0.00592	CcSEcCtD
Gadoteridol—Rhinitis—Methylprednisolone—ankylosing spondylitis	0.0059	0.0059	CcSEcCtD
Gadoteridol—Anaphylactoid reaction—Methotrexate—ankylosing spondylitis	0.00582	0.00582	CcSEcCtD
Gadoteridol—Erythema—Prednisolone—ankylosing spondylitis	0.00559	0.00559	CcSEcCtD
Gadoteridol—Bradycardia—Betamethasone—ankylosing spondylitis	0.00545	0.00545	CcSEcCtD
Gadoteridol—Bradycardia—Dexamethasone—ankylosing spondylitis	0.00545	0.00545	CcSEcCtD
Gadoteridol—Ill-defined disorder—Prednisolone—ankylosing spondylitis	0.00518	0.00518	CcSEcCtD
Gadoteridol—Erythema—Triamcinolone—ankylosing spondylitis	0.00514	0.00514	CcSEcCtD
Gadoteridol—Erythema—Methylprednisolone—ankylosing spondylitis	0.00512	0.00512	CcSEcCtD
Gadoteridol—Malaise—Prednisolone—ankylosing spondylitis	0.00504	0.00504	CcSEcCtD
Gadoteridol—Dysgeusia—Triamcinolone—ankylosing spondylitis	0.00503	0.00503	CcSEcCtD
Gadoteridol—Syncope—Prednisolone—ankylosing spondylitis	0.00501	0.00501	CcSEcCtD
Gadoteridol—Loss of consciousness—Prednisolone—ankylosing spondylitis	0.00491	0.00491	CcSEcCtD
Gadoteridol—Convulsion—Prednisolone—ankylosing spondylitis	0.00484	0.00484	CcSEcCtD
Gadoteridol—Hypertension—Prednisolone—ankylosing spondylitis	0.00482	0.00482	CcSEcCtD
Gadoteridol—Ill-defined disorder—Triamcinolone—ankylosing spondylitis	0.00477	0.00477	CcSEcCtD
Gadoteridol—Ill-defined disorder—Methylprednisolone—ankylosing spondylitis	0.00476	0.00476	CcSEcCtD
Gadoteridol—Bradycardia—Prednisone—ankylosing spondylitis	0.00475	0.00475	CcSEcCtD
Gadoteridol—Discomfort—Prednisolone—ankylosing spondylitis	0.0047	0.0047	CcSEcCtD
Gadoteridol—Erythema—Betamethasone—ankylosing spondylitis	0.00466	0.00466	CcSEcCtD
Gadoteridol—Erythema—Dexamethasone—ankylosing spondylitis	0.00466	0.00466	CcSEcCtD
Gadoteridol—Malaise—Triamcinolone—ankylosing spondylitis	0.00463	0.00463	CcSEcCtD
Gadoteridol—Malaise—Methylprednisolone—ankylosing spondylitis	0.00462	0.00462	CcSEcCtD
Gadoteridol—Syncope—Triamcinolone—ankylosing spondylitis	0.00461	0.00461	CcSEcCtD
Gadoteridol—Syncope—Methylprednisolone—ankylosing spondylitis	0.0046	0.0046	CcSEcCtD
Gadoteridol—Oedema—Prednisolone—ankylosing spondylitis	0.00456	0.00456	CcSEcCtD
Gadoteridol—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.00456	0.00456	CcSEcCtD
Gadoteridol—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.00451	0.00451	CcSEcCtD
Gadoteridol—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.0045	0.0045	CcSEcCtD
Gadoteridol—Shock—Prednisolone—ankylosing spondylitis	0.00448	0.00448	CcSEcCtD
Gadoteridol—Cough—Triamcinolone—ankylosing spondylitis	0.00448	0.00448	CcSEcCtD
Gadoteridol—Convulsion—Triamcinolone—ankylosing spondylitis	0.00445	0.00445	CcSEcCtD
Gadoteridol—Convulsion—Methylprednisolone—ankylosing spondylitis	0.00444	0.00444	CcSEcCtD
Gadoteridol—Hypertension—Triamcinolone—ankylosing spondylitis	0.00443	0.00443	CcSEcCtD
Gadoteridol—Hypertension—Methylprednisolone—ankylosing spondylitis	0.00442	0.00442	CcSEcCtD
Gadoteridol—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.00441	0.00441	CcSEcCtD
Gadoteridol—Anxiety—Methylprednisolone—ankylosing spondylitis	0.00435	0.00435	CcSEcCtD
Gadoteridol—Flushing—Prednisone—ankylosing spondylitis	0.00433	0.00433	CcSEcCtD
Gadoteridol—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.00432	0.00432	CcSEcCtD
Gadoteridol—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.00432	0.00432	CcSEcCtD
Gadoteridol—Discomfort—Triamcinolone—ankylosing spondylitis	0.00432	0.00432	CcSEcCtD
Gadoteridol—Discomfort—Methylprednisolone—ankylosing spondylitis	0.00431	0.00431	CcSEcCtD
Gadoteridol—Dry mouth—Triamcinolone—ankylosing spondylitis	0.00428	0.00428	CcSEcCtD
Gadoteridol—Malaise—Betamethasone—ankylosing spondylitis	0.0042	0.0042	CcSEcCtD
Gadoteridol—Malaise—Dexamethasone—ankylosing spondylitis	0.0042	0.0042	CcSEcCtD
Gadoteridol—Oedema—Triamcinolone—ankylosing spondylitis	0.00419	0.00419	CcSEcCtD
Gadoteridol—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.00419	0.00419	CcSEcCtD
Gadoteridol—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.00418	0.00418	CcSEcCtD
Gadoteridol—Syncope—Betamethasone—ankylosing spondylitis	0.00418	0.00418	CcSEcCtD
Gadoteridol—Syncope—Dexamethasone—ankylosing spondylitis	0.00418	0.00418	CcSEcCtD
Gadoteridol—Sweating—Methotrexate—ankylosing spondylitis	0.00416	0.00416	CcSEcCtD
Gadoteridol—Shock—Triamcinolone—ankylosing spondylitis	0.00412	0.00412	CcSEcCtD
Gadoteridol—Shock—Methylprednisolone—ankylosing spondylitis	0.00412	0.00412	CcSEcCtD
Gadoteridol—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.0041	0.0041	CcSEcCtD
Gadoteridol—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.0041	0.0041	CcSEcCtD
Gadoteridol—Paraesthesia—Prednisolone—ankylosing spondylitis	0.00409	0.00409	CcSEcCtD
Gadoteridol—Erythema—Prednisone—ankylosing spondylitis	0.00406	0.00406	CcSEcCtD
Gadoteridol—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.00405	0.00405	CcSEcCtD
Gadoteridol—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.00404	0.00404	CcSEcCtD
Gadoteridol—Convulsion—Dexamethasone—ankylosing spondylitis	0.00404	0.00404	CcSEcCtD
Gadoteridol—Convulsion—Betamethasone—ankylosing spondylitis	0.00404	0.00404	CcSEcCtD
Gadoteridol—Hypertension—Betamethasone—ankylosing spondylitis	0.00402	0.00402	CcSEcCtD
Gadoteridol—Hypertension—Dexamethasone—ankylosing spondylitis	0.00402	0.00402	CcSEcCtD
Gadoteridol—Anxiety—Dexamethasone—ankylosing spondylitis	0.00395	0.00395	CcSEcCtD
Gadoteridol—Anxiety—Betamethasone—ankylosing spondylitis	0.00395	0.00395	CcSEcCtD
Gadoteridol—Discomfort—Dexamethasone—ankylosing spondylitis	0.00392	0.00392	CcSEcCtD
Gadoteridol—Discomfort—Betamethasone—ankylosing spondylitis	0.00392	0.00392	CcSEcCtD
Gadoteridol—Hypotension—Methylprednisolone—ankylosing spondylitis	0.00391	0.00391	CcSEcCtD
Gadoteridol—Pain—Prednisolone—ankylosing spondylitis	0.0039	0.0039	CcSEcCtD
Gadoteridol—Oedema—Betamethasone—ankylosing spondylitis	0.0038	0.0038	CcSEcCtD
Gadoteridol—Oedema—Dexamethasone—ankylosing spondylitis	0.0038	0.0038	CcSEcCtD
Gadoteridol—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.0038	0.0038	CcSEcCtD
Gadoteridol—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.0038	0.0038	CcSEcCtD
Gadoteridol—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.00377	0.00377	CcSEcCtD
Gadoteridol—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.00376	0.00376	CcSEcCtD
Gadoteridol—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.00376	0.00376	CcSEcCtD
Gadoteridol—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.00376	0.00376	CcSEcCtD
Gadoteridol—Shock—Dexamethasone—ankylosing spondylitis	0.00374	0.00374	CcSEcCtD
Gadoteridol—Shock—Betamethasone—ankylosing spondylitis	0.00374	0.00374	CcSEcCtD
Gadoteridol—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.00374	0.00374	CcSEcCtD
Gadoteridol—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.00368	0.00368	CcSEcCtD
Gadoteridol—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.00368	0.00368	CcSEcCtD
Gadoteridol—Malaise—Prednisone—ankylosing spondylitis	0.00366	0.00366	CcSEcCtD
Gadoteridol—Syncope—Prednisone—ankylosing spondylitis	0.00364	0.00364	CcSEcCtD
Gadoteridol—Tinnitus—Methotrexate—ankylosing spondylitis	0.00363	0.00363	CcSEcCtD
Gadoteridol—Urticaria—Prednisolone—ankylosing spondylitis	0.00362	0.00362	CcSEcCtD
Gadoteridol—Pain—Triamcinolone—ankylosing spondylitis	0.00358	0.00358	CcSEcCtD
Gadoteridol—Loss of consciousness—Prednisone—ankylosing spondylitis	0.00357	0.00357	CcSEcCtD
Gadoteridol—Hypotension—Betamethasone—ankylosing spondylitis	0.00355	0.00355	CcSEcCtD
Gadoteridol—Hypotension—Dexamethasone—ankylosing spondylitis	0.00355	0.00355	CcSEcCtD
Gadoteridol—Convulsion—Prednisone—ankylosing spondylitis	0.00352	0.00352	CcSEcCtD
Gadoteridol—Hypertension—Prednisone—ankylosing spondylitis	0.0035	0.0035	CcSEcCtD
Gadoteridol—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.00345	0.00345	CcSEcCtD
Gadoteridol—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.00345	0.00345	CcSEcCtD
Gadoteridol—Anxiety—Prednisone—ankylosing spondylitis	0.00344	0.00344	CcSEcCtD
Gadoteridol—Paraesthesia—Betamethasone—ankylosing spondylitis	0.00342	0.00342	CcSEcCtD
Gadoteridol—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.00342	0.00342	CcSEcCtD
Gadoteridol—Discomfort—Prednisone—ankylosing spondylitis	0.00341	0.00341	CcSEcCtD
Gadoteridol—Erythema—Methotrexate—ankylosing spondylitis	0.00339	0.00339	CcSEcCtD
Gadoteridol—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.00336	0.00336	CcSEcCtD
Gadoteridol—Urticaria—Triamcinolone—ankylosing spondylitis	0.00333	0.00333	CcSEcCtD
Gadoteridol—Urticaria—Methylprednisolone—ankylosing spondylitis	0.00332	0.00332	CcSEcCtD
Gadoteridol—Dysgeusia—Methotrexate—ankylosing spondylitis	0.00332	0.00332	CcSEcCtD
Gadoteridol—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.00331	0.00331	CcSEcCtD
Gadoteridol—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.00331	0.00331	CcSEcCtD
Gadoteridol—Oedema—Prednisone—ankylosing spondylitis	0.00331	0.00331	CcSEcCtD
Gadoteridol—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.00331	0.00331	CcSEcCtD
Gadoteridol—Shock—Prednisone—ankylosing spondylitis	0.00326	0.00326	CcSEcCtD
Gadoteridol—Pain—Betamethasone—ankylosing spondylitis	0.00325	0.00325	CcSEcCtD
Gadoteridol—Pain—Dexamethasone—ankylosing spondylitis	0.00325	0.00325	CcSEcCtD
Gadoteridol—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.0032	0.0032	CcSEcCtD
Gadoteridol—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.00315	0.00315	CcSEcCtD
Gadoteridol—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.00313	0.00313	CcSEcCtD
Gadoteridol—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.00313	0.00313	CcSEcCtD
Gadoteridol—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.00309	0.00309	CcSEcCtD
Gadoteridol—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.00308	0.00308	CcSEcCtD
Gadoteridol—Malaise—Methotrexate—ankylosing spondylitis	0.00306	0.00306	CcSEcCtD
Gadoteridol—Urticaria—Dexamethasone—ankylosing spondylitis	0.00302	0.00302	CcSEcCtD
Gadoteridol—Urticaria—Betamethasone—ankylosing spondylitis	0.00302	0.00302	CcSEcCtD
Gadoteridol—Dizziness—Prednisolone—ankylosing spondylitis	0.00301	0.00301	CcSEcCtD
Gadoteridol—Abdominal pain—Betamethasone—ankylosing spondylitis	0.00301	0.00301	CcSEcCtD
Gadoteridol—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.00301	0.00301	CcSEcCtD
Gadoteridol—Body temperature increased—Betamethasone—ankylosing spondylitis	0.00301	0.00301	CcSEcCtD
Gadoteridol—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.00301	0.00301	CcSEcCtD
Gadoteridol—Paraesthesia—Prednisone—ankylosing spondylitis	0.00297	0.00297	CcSEcCtD
Gadoteridol—Pruritus—Triamcinolone—ankylosing spondylitis	0.00297	0.00297	CcSEcCtD
Gadoteridol—Cough—Methotrexate—ankylosing spondylitis	0.00296	0.00296	CcSEcCtD
Gadoteridol—Pruritus—Methylprednisolone—ankylosing spondylitis	0.00296	0.00296	CcSEcCtD
Gadoteridol—Convulsion—Methotrexate—ankylosing spondylitis	0.00294	0.00294	CcSEcCtD
Gadoteridol—Chest pain—Methotrexate—ankylosing spondylitis	0.00289	0.00289	CcSEcCtD
Gadoteridol—Rash—Prednisolone—ankylosing spondylitis	0.00287	0.00287	CcSEcCtD
Gadoteridol—Dermatitis—Prednisolone—ankylosing spondylitis	0.00287	0.00287	CcSEcCtD
Gadoteridol—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.00286	0.00286	CcSEcCtD
Gadoteridol—Headache—Prednisolone—ankylosing spondylitis	0.00286	0.00286	CcSEcCtD
Gadoteridol—Discomfort—Methotrexate—ankylosing spondylitis	0.00285	0.00285	CcSEcCtD
Gadoteridol—Dizziness—Triamcinolone—ankylosing spondylitis	0.00277	0.00277	CcSEcCtD
Gadoteridol—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.00277	0.00277	CcSEcCtD
Gadoteridol—Dizziness—Methylprednisolone—ankylosing spondylitis	0.00277	0.00277	CcSEcCtD
Gadoteridol—Feeling abnormal—Prednisone—ankylosing spondylitis	0.00273	0.00273	CcSEcCtD
Gadoteridol—Nausea—Prednisolone—ankylosing spondylitis	0.00271	0.00271	CcSEcCtD
Gadoteridol—Pruritus—Betamethasone—ankylosing spondylitis	0.00269	0.00269	CcSEcCtD
Gadoteridol—Pruritus—Dexamethasone—ankylosing spondylitis	0.00269	0.00269	CcSEcCtD
Gadoteridol—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.00268	0.00268	CcSEcCtD
Gadoteridol—Vomiting—Triamcinolone—ankylosing spondylitis	0.00267	0.00267	CcSEcCtD
Gadoteridol—Vomiting—Methylprednisolone—ankylosing spondylitis	0.00266	0.00266	CcSEcCtD
Gadoteridol—Rash—Triamcinolone—ankylosing spondylitis	0.00264	0.00264	CcSEcCtD
Gadoteridol—Dermatitis—Triamcinolone—ankylosing spondylitis	0.00264	0.00264	CcSEcCtD
Gadoteridol—Rash—Methylprednisolone—ankylosing spondylitis	0.00264	0.00264	CcSEcCtD
Gadoteridol—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.00263	0.00263	CcSEcCtD
Gadoteridol—Urticaria—Prednisone—ankylosing spondylitis	0.00263	0.00263	CcSEcCtD
Gadoteridol—Headache—Triamcinolone—ankylosing spondylitis	0.00263	0.00263	CcSEcCtD
Gadoteridol—Headache—Methylprednisolone—ankylosing spondylitis	0.00262	0.00262	CcSEcCtD
Gadoteridol—Abdominal pain—Prednisone—ankylosing spondylitis	0.00262	0.00262	CcSEcCtD
Gadoteridol—Body temperature increased—Prednisone—ankylosing spondylitis	0.00262	0.00262	CcSEcCtD
Gadoteridol—Diarrhoea—Betamethasone—ankylosing spondylitis	0.0026	0.0026	CcSEcCtD
Gadoteridol—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.0026	0.0026	CcSEcCtD
Gadoteridol—Hypotension—Methotrexate—ankylosing spondylitis	0.00259	0.00259	CcSEcCtD
Gadoteridol—Dizziness—Dexamethasone—ankylosing spondylitis	0.00252	0.00252	CcSEcCtD
Gadoteridol—Dizziness—Betamethasone—ankylosing spondylitis	0.00252	0.00252	CcSEcCtD
Gadoteridol—Nausea—Triamcinolone—ankylosing spondylitis	0.00249	0.00249	CcSEcCtD
Gadoteridol—Paraesthesia—Methotrexate—ankylosing spondylitis	0.00249	0.00249	CcSEcCtD
Gadoteridol—Nausea—Methylprednisolone—ankylosing spondylitis	0.00248	0.00248	CcSEcCtD
Gadoteridol—Dyspnoea—Methotrexate—ankylosing spondylitis	0.00247	0.00247	CcSEcCtD
Gadoteridol—Hypersensitivity—Prednisone—ankylosing spondylitis	0.00244	0.00244	CcSEcCtD
Gadoteridol—Vomiting—Betamethasone—ankylosing spondylitis	0.00242	0.00242	CcSEcCtD
Gadoteridol—Vomiting—Dexamethasone—ankylosing spondylitis	0.00242	0.00242	CcSEcCtD
Gadoteridol—Rash—Betamethasone—ankylosing spondylitis	0.0024	0.0024	CcSEcCtD
Gadoteridol—Rash—Dexamethasone—ankylosing spondylitis	0.0024	0.0024	CcSEcCtD
Gadoteridol—Dermatitis—Dexamethasone—ankylosing spondylitis	0.0024	0.0024	CcSEcCtD
Gadoteridol—Dermatitis—Betamethasone—ankylosing spondylitis	0.0024	0.0024	CcSEcCtD
Gadoteridol—Headache—Dexamethasone—ankylosing spondylitis	0.00238	0.00238	CcSEcCtD
Gadoteridol—Headache—Betamethasone—ankylosing spondylitis	0.00238	0.00238	CcSEcCtD
Gadoteridol—Pain—Methotrexate—ankylosing spondylitis	0.00237	0.00237	CcSEcCtD
Gadoteridol—Pruritus—Prednisone—ankylosing spondylitis	0.00234	0.00234	CcSEcCtD
Gadoteridol—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.00228	0.00228	CcSEcCtD
Gadoteridol—Diarrhoea—Prednisone—ankylosing spondylitis	0.00227	0.00227	CcSEcCtD
Gadoteridol—Nausea—Betamethasone—ankylosing spondylitis	0.00226	0.00226	CcSEcCtD
Gadoteridol—Nausea—Dexamethasone—ankylosing spondylitis	0.00226	0.00226	CcSEcCtD
Gadoteridol—Urticaria—Methotrexate—ankylosing spondylitis	0.0022	0.0022	CcSEcCtD
Gadoteridol—Dizziness—Prednisone—ankylosing spondylitis	0.00219	0.00219	CcSEcCtD
Gadoteridol—Abdominal pain—Methotrexate—ankylosing spondylitis	0.00219	0.00219	CcSEcCtD
Gadoteridol—Body temperature increased—Methotrexate—ankylosing spondylitis	0.00219	0.00219	CcSEcCtD
Gadoteridol—Vomiting—Prednisone—ankylosing spondylitis	0.00211	0.00211	CcSEcCtD
Gadoteridol—Rash—Prednisone—ankylosing spondylitis	0.00209	0.00209	CcSEcCtD
Gadoteridol—Dermatitis—Prednisone—ankylosing spondylitis	0.00209	0.00209	CcSEcCtD
Gadoteridol—Headache—Prednisone—ankylosing spondylitis	0.00208	0.00208	CcSEcCtD
Gadoteridol—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.00204	0.00204	CcSEcCtD
Gadoteridol—Nausea—Prednisone—ankylosing spondylitis	0.00197	0.00197	CcSEcCtD
Gadoteridol—Pruritus—Methotrexate—ankylosing spondylitis	0.00196	0.00196	CcSEcCtD
Gadoteridol—Diarrhoea—Methotrexate—ankylosing spondylitis	0.00189	0.00189	CcSEcCtD
Gadoteridol—Dizziness—Methotrexate—ankylosing spondylitis	0.00183	0.00183	CcSEcCtD
Gadoteridol—Vomiting—Methotrexate—ankylosing spondylitis	0.00176	0.00176	CcSEcCtD
Gadoteridol—Rash—Methotrexate—ankylosing spondylitis	0.00175	0.00175	CcSEcCtD
Gadoteridol—Dermatitis—Methotrexate—ankylosing spondylitis	0.00174	0.00174	CcSEcCtD
Gadoteridol—Headache—Methotrexate—ankylosing spondylitis	0.00173	0.00173	CcSEcCtD
Gadoteridol—Nausea—Methotrexate—ankylosing spondylitis	0.00164	0.00164	CcSEcCtD
